ADPT - Adaptive Biotechnologies Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$24.38
DETAILS
HIGH:
$27.50
LOW:
$20.00
MEDIAN:
$25.00
CONSENSUS:
$24.38
UPSIDE:
0.41%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 29,993,708 | $643.4M | 1.8% | -- | UNCHANGED |
| Cooperman | 4,625,859 | $99.2M | 0.0% | +2,660,249 | INCREASED |
| Greenblatt | 74,732 | $1.6M | 0.0% | -16,013 | DECREASED |
| Dalio | 40,087 | $859,866 | 0.0% | -49,620 | DECREASED |
| Wood | 0 | $0 | -- | -1,021,808 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-31 | OWEN KATEY EINTERZ | director | G-Gift | 12,539 | -- | -- |
| 2026-08-26 | OWEN KATEY EINTERZ | director | SELL | 9,615 | $26.00 | $250K |
| 2026-08-18 | HERSHBERG ROBERT | director | SELL | 15,664 | $24.41 | $382K |
| 2026-08-18 | HERSHBERG ROBERT | director | M-Exempt | 15,000 | $6.32 | $95K |
| 2026-08-18 | HERSHBERG ROBERT | director | SELL | 15,000 | $24.39 | $366K |
| 2026-08-17 | ROBINS CHAD M | director, officer: CEO and Chairman | SELL | 318,799 | $25.08 | $8.0M |
| 2026-08-18 | ROBINS CHAD M | director, officer: CEO and Chairman | SELL | 278,472 | $24.48 | $6.8M |
| 2026-08-17 | ROBINS CHAD M | director, officer: CEO and Chairman | SELL | 2,525 | $25.57 | $65K |
| 2026-08-18 | ROBINS CHAD M | director, officer: CEO and Chairman | SELL | 204 | $25.14 | $5K |
| 2026-08-17 | ROBINS CHAD M | director, officer: CEO and Chairman | M-Exempt | 321,324 | $6.55 | $2.1M |
| 2026-08-18 | ROBINS CHAD M | director, officer: CEO and Chairman | M-Exempt | 278,676 | $6.55 | $1.8M |
| 2026-08-17 | NEUPERT PETER M | director | M-Exempt | 15,000 | $6.32 | $95K |
| 2026-08-17 | NEUPERT PETER M | director | SELL | 15,000 | $25.23 | $378K |
| 2026-08-17 | NEUPERT PETER M | director | SELL | 40,000 | $25.10 | $1.0M |
| 2026-08-17 | NEUPERT PETER M | director | SELL | 69,690 | $25.16 | $1.8M |
| 2026-08-10 | BOBULSKY SUSAN | officer: Chief Commercial Officer, MRD | SELL | 3,000 | $25.00 | $75K |
| 2026-07-30 | BOBULSKY SUSAN | officer: Chief Commercial Officer, MRD | SELL | 1,299 | $24.00 | $31K |
| 2026-07-21 | ROBINS HARLAN S | officer: Chief Scientific Officer | SELL | 278,698 | $21.72 | $6.1M |
| 2026-07-21 | ROBINS HARLAN S | officer: Chief Scientific Officer | SELL | 213,702 | $22.12 | $4.7M |
| 2026-07-21 | ROBINS HARLAN S | officer: Chief Scientific Officer | M-Exempt | 284,800 | $6.55 | $1.9M |
| 2026-07-16 | BOBULSKY SUSAN | officer: Chief Commercial Officer, MRD | SELL | 5,000 | $23.00 | $115K |
| 2026-07-15 | LO FRANCIS | officer: Chief People Officer | M-Exempt | 22,711 | $8.46 | $192K |
| 2026-07-15 | LO FRANCIS | officer: Chief People Officer | M-Exempt | 23,677 | $12.14 | $287K |
| 2026-07-15 | LO FRANCIS | officer: Chief People Officer | SELL | 105,762 | $22.59 | $2.4M |
| 2026-07-15 | LO FRANCIS | officer: Chief People Officer | M-Exempt | 59,374 | $7.80 | $463K |